FdaApplication
BLA 761381
Identifiers
- fda_app_no: BLA761381
Properties
| Property | Value |
|---|---|
| applicant_name | Bristol-Myers Squibb Company |
| application_type | BLA |
| approval_date | 2024-12-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OPDIVO QVANTIG | NIVOLUMAB; HYALURONIDASE-NVHY | 600MG/5ML;10,000UNITS/5ML (120MG/2,000UNITS/ML) | Injection |
| OPDIVO QVANTIG | — | 300MG/2.5ML;5,000UNITS/2.5ML (120MG/2,000UNITS/ML) | Injection |
2 products